medigraphic.com
Instituto Nacional de Salud Pública

2002, Number 2

Next >>

salud publica mex 2002; 44 (2)

Asociación de lesiones bucales con el estado serológico para el VIH

Ramírez-Amador V, Esquivel-Pedraza L, Irigoyen-Camacho E, Anaya-Saavedra G, González-Ramírez I

Language: Spanish
References: 24
Page: 87-91
PDF size: 38.38 Kb.


ABSTRACT

Objective. To estimate the prevalence of oral lesions and its association with HIV serological status. Material and Methods. A cross-sectional descriptive study was conducted between 1998 and 1999 in Mexico City, among 512 subjects attending two information centers of Centro Nacional para la Prevención del VIH/SIDA e ITS (CONASIDA, National Center for Prevention of HIV/AIDS and Sexually Transmitted Infections) for HIV serologic testing. The oral examination was performed without knowledge of the HIV status. Statistical analysis was conducted using Student’s t test, Fisher’s exact test and the χ2 test; odds ratios and 95% CI were also calculated. Results. A total of 512 individuals were examined, 68 of whom were HIV-positive. HIV-related oral lesions (OL), were evident in 65% (44/68) of the HIV-positive individuals; 95% of them consisted in oral candidosis (OC) and hairy leukoplakia (HL). OC and HL were strongly associated with seropositivity to HIV. Conclusions. OC and HL were the oral lesions most strongly associated to HIV seropositivity.


REFERENCES

  1. Patton LL, McKaig R, Strauss R, Rogers D, Eron JJ. Changing prevalence of oral manifestations of human immunodeficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:299-304.

  2. Arendorf TM, Bredekamp B, Cloete CAC, Sauer G. Oral manifestations of HIV infection in 600 South African patients. J Oral Pathol Med 1998; 27:176-179.

  3. Ficarra G. Oral ulcers in HIV-infected patients: An update on epidemiology and diagnosis. Oral Dis 1997;3 Suppl 1:183-189.

  4. Muzyka BC, Glick M. Major aphthous ulcers in patients with HIV disease. Oral Surg Oral Med Oral Pathol 1994;77:116-120.

  5. Glick M, Muzyka BC, Salkin LM, Lurie D. Necrotizing ulcerative periodontitis: A marker for immune deterioration and a predictor for the diagnosis of AIDS. J Periodontol 1994;65:393-397.

  6. Epstein JB. Management of oral Kaposi’s sarcoma and a proposal for clinical staging. Oral Dis 1997;3:S124-S128.

  7. Ramírez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Soto-Ramírez L, González-Ramírez I, Anaya-Saavedra G et al. Oral clinical markers and viral load in a prospective cohort of Mexican HIV-infected patients. AIDS 2001;15: 1910-1911.

  8. Greenspan D, Komaroff E, Redford M, Phelan JA, Navazesh M, Alves MEAF et al. Oral mucosal lesions and HIV viral load in the women’s interagency HIV study (WIHS). J Acquir Immune Defic Syndr 2000;25:44-50.

  9. Margiotta V, Campisi G, Mancusso S, Accurso V, Abbadessa V. HIV infection: Oral lesions, CD4 cell count and viral load in an Italian study population. J Oral Pathol Med 1999;28:173-177.

  10. Patton LL, McKaig RG, Eron Jr JJ, Lawrence HP, Strauss RP. Oral hairy leukoplakia and oral candidiasis as predictors of HIV viral load. AIDS 1999;13:2174-2176.

  11. Greenspan JS. Sentinels and signposts: The epidemiology and significance of the oral manifestations of HIV disease. Oral Dis 1997;3 Suppl 1:13-17.

  12. Ramírez-Amador V, Esquivel-Pedraza L, Ponce de León S, Ponce de León S. Prognostic value of oral candidosis and hairy leukoplakia in 111 Mexican HIV-infected patients. J Oral Pathol Med 1996;25:206-211.

  13. Ramírez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Ponce de León Sa, Ponce de León Se. Oral manifestations of HIV infection by gender and transmission category in Mexico City. J Oral Pathol Med 1998;27:135-140.

  14. Ramírez-Amador V, González A, De la Rosa E, González M, Rivera I, Hernández C et al. Oral lesions in Mexican HIV-infected patients. J Oral Pathol Med 1990;19:482-485.

  15. Palacio H, Hilton JF, Canchola AJ, Greenspan D. Effect of cigarrette smoking on HIV-related oral lesions. J Acquir Immune Defic Syndr 1997;14:338-342.

  16. Research, Science, and Therapy Committee of the American Academy of Peridontology. Epidemiology of periodontal diseases. J Periodontol 1996;67:935-945.

  17. McCarthy GM, Mackie ID, Koval J, Sandhu HS, Daley TD. Factors associated with increased frequency of HIV-related oral candidiasis. J Oral Pathol Med 1991;20:332-336.

  18. European Community. Clearinghouse on oral problems related to HIV infection and WHO collaborating centre on oral manifestations of the immunodeficiency virus. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 1993;22:289-291.

  19. Robinson PG, Challacombe SJ, Sheiham A. Oral examination: A screening tool for HIV infection? Sex Transm Infect 1998;74:345-348.

  20. Shiboski CH, Hilton JF, Greenspan D, Westenhouse JL, Derish P, Vranizan K et al. HIV-Related oral manifestations in two cohorts of women in San Francisco. J Acquir Immune Defic Syndr 1994;7:964-971.

  21. Melnick SL, Engel D, Truelove E, De Rouen T, Morton T, Schubert M et al. Oral mucosal lesions: Association with the presence of antibodies to the human immunodeficiency virus. Oral Surg Oral Med Oral Pathol 1989;68:37-43.

  22. Begg MD, Lamster IB, Panageas KS, Mitchell-Lewis D, Phelan JA, Grbic JT. A prospective study of oral lesions and their predictive value for progression of HIV disease. Oral Dis 1997;3:176-183.

  23. Begg MD, Panageas KS, Mitchell-Lewis D, Bucklan RS, Phelan JA, Lamster IB. Oral lesions as markers of severe immunosupresion in HIV-infected homosexual men and injection drug users. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:276-283.

  24. Glick M, Muzyka BC, Lurie D, Salkin LM. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1994;77: 344-349.




2020     |     www.medigraphic.com